An independent newsroom of one. Every story is cross-referenced across multiple trusted Indian publications, scored, and rewritten without ads, bias, or noise.

News

Politics
Business
Sports
Technology
World
Entertainment

About

How verification works
Saved stories

Legal

Privacy Policy
Terms of Use
Corrections Policy
Contact & Tips

Transparency

No advertising or sponsored content
Every claim links back to its sources
Open-source under the MIT licence
AI cross-verifies before publishing

Built in IndiaDesigned & engineered by Roshhellwett, with the help of Claude & other tools.

Home

Swipe

Saved

Sun Pharma Q4 Results: Cons profit rises 26% YoY — India Verified

Back to all news

Business
Sun Pharma Q4 Results: Cons profit rises 26% YoY

Business22 May 2026 at 03:28 pmQuick read

Sun Pharma Q4 Results: Cons profit rises 26% YoY

Credibility score80 / 100

LowModerateHigh

2sources verified

Sun Pharma's Q4 profit rose 26% YoY. The company's PAT fell 19% sequentially. A final dividend of Rs 5 per share was approved.

AI Credibility Analysis

The score falls in the 70-89 band as it is based on 2 named sources, including Economic Times Markets and Mint Markets, with mostly factual information and minor gaps.

Original Sources

The Economic Times
Mint

How this story was built

Cross-Referenced

2 Sources

Unbiased AI

⚡

Auto-Published

Sun Pharma Q4 Results: Cons profit rises 26% YoY

How this story was built

Related stories

India's inflation rises to 3.5% in April 2026

Oil Markets Face Stress

India blocks China's WTO dispute panel request